Somatuline and cholelithiasis Patient Reports February 12, 2012

Somatuline Side Effects Report #5512641-9
Somatuline side effect was reported by a Physician from on Oct 22, 2007. Male patient, 19 years of age, was diagnosed with obesity  and was treated with Somatuline. After drug was administered, patient experienced the following side effects: cholelithiasis, diabetes mellitus, hypertriglyceridaemia, insulin resistance, liver disorder. Somatuline dosage: 60 MG (60MG, 1 IN 1 M) SUBCUTANEOUS. During the same period patient was treated with GENOTROPIN. Patient was hospitalized. Patient recovered.

Somatuline Side Effects Report #5545477-3
Somatuline side effect was reported by a Consumer or non-health professional from on Nov 26, 2007. Male patient, 19 years of age, was diagnosed with hypothalamo-pituitary disorder, obesity  and was treated with Somatuline. After drug was administered, patient experienced the following side effects: biliary colic, cholelithiasis, diabetes mellitus inadequate control, hypertriglyceridaemia, insulin resistant diabetes. Somatuline dosage: 60 MG (60MG, 1 IN 1 M. During the same period patient was treated with SOMATULINE DEPOT. Patient was hospitalized. Patient recovered.

Somatuline Side Effects Report #5772002-4
Somatuline side effect was reported by a Health Professional from CHINA on May 29, 2008. Male patient, 34 years of age, was diagnosed with acromegaly and was treated with Somatuline. After drug was administered, patient experienced the following side effects: cholecystitis, cholelithiasis, gallbladder polyp. Somatuline dosage: (40 MG, 1 IN 14 D) INTRAMUSCULAR. Patient recovered.